Triple-Negative Breast Cancer, Stem Cells, and African Ancestry
- PMID: 29137951
- DOI: 10.1016/j.ajpath.2017.06.020
Triple-Negative Breast Cancer, Stem Cells, and African Ancestry
Abstract
Triple-negative breast cancers (TNBCs) are more common among African-ancestry populations, such as African Americans and western, sub-Saharan Africans, compared with European-ancestry populations. This phenotype prevalence contributes to disparities in breast cancer outcomes between African Americans and White Americans. Breast cancer stem cells represent the tumor subpopulation involved in metastatic virulence, and ongoing research seeks to characterize the extent to which TNBC versus non-TNBC stem cells may differ. This review summarizes the existing literature regarding TNBCs and stem cells as they pertain to the burden of breast cancer among African-ancestry populations. Additional research related to variations in somatic tumor genomics between the African-American and White-American populations is also summarized. This review furthermore explores the history of insights regarding breast cancer disparities related to racial/ethnic identity, socioeconomic status, and tumor biology.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.JAMA Surg. 2017 May 1;152(5):485-493. doi: 10.1001/jamasurg.2017.0005. JAMA Surg. 2017. PMID: 28355428 Review.
-
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.Ann Surg Oncol. 2016 Nov;23(12):3843-3849. doi: 10.1245/s10434-016-5420-z. Epub 2016 Jul 28. Ann Surg Oncol. 2016. PMID: 27469125
-
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.Breast Cancer Res Treat. 2021 Apr;186(2):391-401. doi: 10.1007/s10549-021-06097-8. Epub 2021 Feb 12. Breast Cancer Res Treat. 2021. PMID: 33576900
-
Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.Breast Cancer Res Treat. 2020 Jul;182(2):503-509. doi: 10.1007/s10549-020-05693-4. Epub 2020 May 21. Breast Cancer Res Treat. 2020. PMID: 32441016 Free PMC article.
-
Disparities in breast cancer and african ancestry: a global perspective.Breast J. 2015 Mar-Apr;21(2):133-9. doi: 10.1111/tbj.12369. Epub 2015 Jan 9. Breast J. 2015. PMID: 25639288 Review.
Cited by
-
Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia.Front Endocrinol (Lausanne). 2023 Nov 9;14:1250189. doi: 10.3389/fendo.2023.1250189. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027092 Free PMC article.
-
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.Front Immunol. 2023 Oct 13;14:1244159. doi: 10.3389/fimmu.2023.1244159. eCollection 2023. Front Immunol. 2023. PMID: 37901240 Free PMC article.
-
Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data.Cancers (Basel). 2023 Aug 30;15(17):4333. doi: 10.3390/cancers15174333. Cancers (Basel). 2023. PMID: 37686609 Free PMC article.
-
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer.Cancers (Basel). 2023 May 18;15(10):2828. doi: 10.3390/cancers15102828. Cancers (Basel). 2023. PMID: 37345165 Free PMC article.
-
Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.Genet Mol Biol. 2022 Feb 2;45(1):e20210172. doi: 10.1590/1678-4685-GMB-2021-0172. eCollection 2022. Genet Mol Biol. 2022. PMID: 35112701 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
